Results for tag: "Aldesleukin"

Aldesleukin is a type of skin cancer drug used to treat melanoma, renal cell carcinoma, and other types of cancer. It is a recombinant form of interleukin-2 (IL-2), a naturally occurring protein that helps regulate the body's immune system. Aldesleukin works by stimulating the body's own immune system to attack cancer cells. It is typically administered intravenously, and can be used in combination with other treatments such as chemotherapy and radiation therapy. The Aldesleukin market is highly competitive, with a number of companies offering products for the treatment of skin cancer. These companies include Novartis, Merck, Bristol-Myers Squibb, and Pfizer. Other companies such as Amgen, Genentech, and Eli Lilly also offer products in the Aldesleukin market. These companies are constantly striving to develop new and improved treatments for skin cancer, and are investing heavily in research and development. Show Less Read more